• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于测定肌酸激酶MB同工酶的微量离心分析仪方法的开发与临床评估。

Development and clinical evaluation of a microcentrifugal analyzer method for determining creatine kinase MB isoenzyme.

作者信息

Massey T H, Butts W C

出版信息

Clin Chem. 1983 Mar;29(3):533-8.

PMID:6337744
Abstract

We have adapted to a microcentrifugal analyzer an immunoinhibition assay for measuring the activity of creatine kinase MB by using an inhibitory antibody for the M monomer. The method actually measures half the MB activity, but results are not multiplied by two because atypical isoenzymes of creatine kinase, including BB, IgG-BB, and the isoenzyme derived from mitochondria, are also detected, if they are present. Results correlated well with an electrophoresis method for 36 serum samples. Myocardial infarction was assessed in 175 patients admitted to our coronary-care unit, with respect to sensitivity (100%) and specificity (98%) when a decision point of 100 U/L (30 degrees C) was chosen for total creatine kinase activity (dithiothreitol-activated) and 6 U/L (30 degrees C) for the isoenzyme (by immunoinhibition). Atypical isoenzymes are easily recognized and confirmed by electrophoresis when the MB activity (by immunoinhibition) exceeds 6 U/L and 20% of the total creatine kinase activity.

摘要

我们对微量离心分析仪进行了改良,采用针对M单体的抑制性抗体,建立了一种免疫抑制测定法来检测肌酸激酶MB的活性。该方法实际测定的是MB活性的一半,但结果无需乘以2,因为如果存在非典型肌酸激酶同工酶,包括BB、IgG-BB以及线粒体来源的同工酶,也能被检测出来。对36份血清样本的检测结果与电泳法高度相关。对收入我们冠心病监护病房的175例患者进行心肌梗死评估时发现,当选择总肌酸激酶活性(二硫苏糖醇激活)的判定点为100 U/L(30℃)、同工酶(通过免疫抑制法)的判定点为6 U/L(30℃)时,该方法的敏感性为100%,特异性为98%。当MB活性(通过免疫抑制法)超过6 U/L且占总肌酸激酶活性的20%时,非典型同工酶很容易通过电泳识别并确认。

相似文献

1
Development and clinical evaluation of a microcentrifugal analyzer method for determining creatine kinase MB isoenzyme.一种用于测定肌酸激酶MB同工酶的微量离心分析仪方法的开发与临床评估。
Clin Chem. 1983 Mar;29(3):533-8.
2
Automated creatine kinase-MB estimation by immuno-inhibition: a clinical evaluation.
Clin Chem. 1980 Apr;26(5):568-72.
3
Influence of autoantibodies to creatine kinase-BB on assays for MB isoenzyme.抗肌酸激酶-BB自身抗体对肌酸激酶同工酶MB检测的影响。
Clin Chem. 1985 Jul;31(7):1189-92.
4
Use of creatine kinase MB isoenzyme for diagnosing myocardial infarction when total creatine kinase activity is high.
Clin Chem. 1988 Nov;34(11):2208-10.
5
Determination of creatine kinase isoenzyme MB activity in serum using immunological inhibition of creatine kinase M subunit activity. Activity kinetics and diagnostic significance in myocardial infarction.利用肌酸激酶M亚基活性的免疫抑制法测定血清中肌酸激酶同工酶MB活性。活性动力学及在心肌梗死中的诊断意义。
Clin Chim Acta. 1976 Dec;73(3):445-51. doi: 10.1016/0009-8981(76)90146-7.
6
Creatine kinase B-subunit activity in serum after immunoinhibition of M-subunit activity.M亚基活性经免疫抑制后血清中的肌酸激酶B亚基活性
Clin Chem. 1979 Jul;25(7):1274-80.
7
Analytical and clinical evaluation of creatine kinase MB mass assay by IMx: comparison with MB isoenzyme activity and serum myoglobin for early diagnosis of myocardial infarction.IMx法检测肌酸激酶MB质量的分析与临床评估:与MB同工酶活性及血清肌红蛋白用于心肌梗死早期诊断的比较
Clin Chem. 1992 Dec;38(12):2380-6.
8
Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals.评估和比较免疫抑制法与免疫沉淀法,以区分患者和健康个体中肌酸激酶同工酶的巨分子形式中的MB和BB。
Clin Chem. 1982 Oct;28(10):2017-21.
9
Simultaneous occurrence of the MB isoenzyme of creatine kinase and macro creatine kinase type 1 in a patient with acute myocardial infarction.一名急性心肌梗死患者同时出现肌酸激酶MB同工酶和1型巨肌酸激酶。
Int J Cardiol. 1991 May;31(2):253-5. doi: 10.1016/0167-5273(91)90227-g.
10
High creatine kinase MB isoenzyme activity associated with a rhabdomyosarcoma.高肌酸激酶同工酶MB活性与横纹肌肉瘤相关。
Clin Chem. 1983 Aug;29(8):1549-50.